Friday, July 26, 2013

Ubretid ® | Distigmine bromide a treatment of post operative intestinal atony and meteorism

Ubretid ®  | Distigmine bromide a treatment of post operative intestinal atony and meteorism

Ubretid ®

Distigmine bromide 5 mg / tab.

Company Name
ADCO/Nycomed - Austria

Pharmaceutical form
Tablets

Package
Box of 20 tablets in strips 5 mg / tablet.

Indications
- Prophylactic and therapeutic treatment of post operative intestinal atony and meteorism, particulary in operations with laparotomy, post operative paralytic ileus and infectious diseases, peritonitis, atonic constipation. - In atony and disturded evacuation of the urinary bladder and ureters after operation, spinal anaethesia, in treament with neuroleptics. - Neurogenic bladder of cerebral origin, in diseases of the spinal cord; pelvic trauma, Lesions of the pelvic nerve in surgical treatment of carcinoma of the cervix or the rectum. - Myasthenia gravis, incomplete after flaccid paralysis after poliomyelitis, diphtheria .... etc

Warning & Precautions
- Not to be given to newly born . - Pregnancy and lactation period. take Ubretid if specifically prescribed by your doctor. - This drug may import the mental alterness required for driving a car and operating machinery.

Product Type
Human

Dosage
Initially 5 mg (1 tablet) daily, is taken in the morning on empty stomach half an hour before breakfast, depending on the response increase to 2 tablest daily or decrease to one tablet every second or third day

Adverse Reactions
Intestinal spasms, sweating, salivation, nausea, vomiting and diarrhoea (muscarine - like effects). Fasciculation and muscular weakness , disturbed deglutition can occur with large doses (nicotine -like effects).

Contra Indications
- Recent myocardial infarction. - Severe hypotension, arterioventricular of impulse conduction, - Spastic states of the intestinal, biliary, urinary tracts and the bronchi. - Caution is necessary in hyperthyoidism

Drug Interactions
None




Ubretid ® Ampoule
Distigmine bromide 0.5 mg / ml




Company Name
ADCO/Nycomed - Austria

Pharmaceutical form
I.M.Ampoule

Package
Box of 25 ampoules each 0.5 mg / mlBox of 3 ampoules each 0.5 mg / mll. Box of 5 ampoules each 0.5 mg / mll.

Indications
- Prophylactic and therapeutic treatment of post operative intestinal atony and meteorism, particulary in operations with laparotomy, post operative paralytic ileus and infectious diseases, peritonitis, atonic constipation. - In atony and disturded evacuation of the urinary bladder and ureters after operation, spinal anaethesia, in treament with neuroleptics. - Neurogenic bladder of cerebral origin, in diseases of the spinal cord; pelvic trauma, Lesions of the pelvic nerve in surgical treatment of carcinoma of the cervix or the rectum. - Myasthenia gravis, incomplete after flaccid paralysis after poliomyelitis, diphtheria .... etc

Warning & Precautions
- Not to be given to newly born . - Pregnancy and lactation period. take Ubretid if specifically prescribed by your doctor. - This drug may import the mental alterness required for driving a car and operating machinery.

Product Type
Human

Dosage
Ampoules: 0.5 mg to not more than 1 mg I. M ., not to be repeated until after 24 hours have elapesd. Long term therapy can be given at 2 or 3 day intervals.

Adverse Reactions
Intestinal spasms, sweating, salivation, nausea, vomiting and diarrhoea (muscarine - like effects). Fasciculation and muscular weakness , disturbed deglutition can occur with large doses (nicotine -like effects).

Contra Indications
- Recent myocardial infarction. - Severe hypotension, arterioventricular of impulse conduction, - Spastic states of the intestinal, biliary, urinary tracts and the bronchi. - Caution is necessary in hyperthyoidism.

Drug Interactions
None
5 EgyDrug Index: Ubretid ® | Distigmine bromide a treatment of post operative intestinal atony and meteorism Ubretid ® Distigmine bromide 5 mg / tab. Company Name ADCO/Nycomed - Austria Pharmaceutical form Tablets Package Box of 20 tab...

No comments:

Post a Comment